Corrigendum to "NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma" [Canc. Lett. 476 (2020) 48-56]
Cancer Lett. 2021 Feb 28:499:2.
doi: 10.1016/j.canlet.2020.06.007.
Epub 2020 Jun 17.
1 Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong.
2 Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong.
3 Department of Pathology, Queen Mary Hospital, The University of Hong Kong, Hong Kong; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong.
4 Department of Pathology, Sun Yat Sen University Cancer Center, China.
5 State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Hong Kong.
6 School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong.
7 Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong; State Key Laboratory of Chemical Biology and Drug Discovery, The Hong Kong Polytechnic University, Hong Kong. Electronic address: terence.kw.lee@polyu.edu.hk.